Review of Biguanide (Metformin) Toxicity

Volume: 34, Issue: 11-12, Pages: 863 - 876
Published: Aug 21, 2018
Abstract
In the 1920s, guanidine, the active component of Galega officinalis, was shown to lower glucose levels and used to synthesize several antidiabetic compounds. Metformin (1,1 dimethylbiguanide) is the most well-known and currently the only marketed biguanide in the United States, United Kingdom, Canada, and Australia for the treatment of non-insulin-dependent diabetes mellitus. Although phenformin was removed from the US market in the 1970s, it is...
Paper Details
Title
Review of Biguanide (Metformin) Toxicity
Published Date
Aug 21, 2018
Volume
34
Issue
11-12
Pages
863 - 876
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.